Novaliq Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$158M
- Investors
-
1
Novaliq General Information
Description
Operator of a biopharmaceutical company intended to address the unmet medical needs of millions of patients with eye disease. The company's drugs focus on the development and commercialization of ocular therapeutics for dry eye disease, with products that are beneficial for the ocular surface, micro-dosed and non-preserved, targeting multiple ophthalmic diseases with a smart eye drop, enabling ophthalmologists to get a suitable option for eye treatment and preserve eyesight in millions of patients around the globe.
Contact Information
Website
www.novaliq.comCorporate Office
- Im Neuenheimer Feld 515
- 69120 Heidelberg
- Germany
Corporate Office
- Im Neuenheimer Feld 515
- 69120 Heidelberg
- Germany
Novaliq Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 11-Oct-2018 | $158M | Completed | Clinical Trials - Phase 3 | ||
| 4. Later Stage VC | 11-Apr-2013 | Completed | Clinical Trials - Phase 3 | |||
| 3. Later Stage VC | 02-May-2012 | Completed | Clinical Trials - Phase 3 | |||
| 2. Early Stage VC | 15-Jul-2011 | $3.29M | $12.5M | Completed | Clinical Trials - Phase 3 | |
| 1. Early Stage VC | 01-Jan-2007 | $9.2M | $9.2M | Completed | Pre-Clinical Trials |
Novaliq Comparisons
Industry
Financing
Details
Novaliq Competitors (37)
One of Novaliq’s 37 competitors is Renova Therapeutics, a Venture Capital-Backed company based in Carlsbad, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Renova Therapeutics | Venture Capital-Backed | Carlsbad, CA | ||||
| BioMarin Pharmaceutical | Formerly PE-Backed | San Rafael, CA | ||||
| Intas Pharmaceuticals | Private Equity-Backed | Ahmedabad, India | ||||
| Astellas Pharma | Corporation | Tokyo, Japan | ||||
| CSL Behring (Biotechnology) | Corporation | Vienna, Austria |
Novaliq Patents
Novaliq Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026003129-A1 | Stabilization of (r)-ruxolitinib | Pending | 26-Jun-2024 | ||
| WO-2025133214-A1 | Ophthalmic polypeptide compositions for the treatment of posterior eye disorders | Inactive | 21-Dec-2023 | ||
| AU-2024371512-A1 | Semifluorinated alkane compositions comprising lifitegrast | Pending | 02-Nov-2023 | ||
| EP-4801467-A1 | Semifluorinated alkane compositions comprising lifitegrast | Pending | 02-Nov-2023 | ||
| WO-2025093739-A1 | Semifluorinated alkane compositions comprising lifitegrast | Inactive | 02-Nov-2023 | A61K9/0048 |
Novaliq Signals
Novaliq Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Dievini | Venture Capital | Minority |
Novaliq Investments (1)
Novaliq’s most recent deal was a Joint Venture with Betaliq. The deal was made on 10-Oct-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Betaliq | 10-Oct-2018 | Joint Venture | Drug Discovery |
Novaliq FAQs
-
When was Novaliq founded?
Novaliq was founded in 2007.
-
Where is Novaliq headquartered?
Novaliq is headquartered in Heidelberg, Germany.
-
What is the size of Novaliq?
Novaliq has 20 total employees.
-
What industry is Novaliq in?
Novaliq’s primary industry is Pharmaceuticals.
-
Is Novaliq a private or public company?
Novaliq is a Private company.
-
What is Novaliq’s current revenue?
The current revenue for Novaliq is .
-
How much funding has Novaliq raised over time?
Novaliq has raised $194M.
-
Who are Novaliq’s investors?
Dievini has invested in Novaliq.
-
Who are Novaliq’s competitors?
Renova Therapeutics, BioMarin Pharmaceutical, Intas Pharmaceuticals, Astellas Pharma, and CSL Behring (Biotechnology) are some of the 37 competitors of Novaliq.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process